Ipamorelin vs CJC-1295 (No DAC): prices, identity and regulatory status (2026)
Ipamorelin and CJC-1295 (No DAC) are compared here as separately listed products. CJC-1295 (No DAC)'s exact identity is not resolved to a public chemical record here, so this page does not state how the two relate chemically; Ipamorelin is a 5-amino-acid peptide (C38H49N9O5). Check each supplier's specification and certificate of analysis. Neither product has a current in-stock price right now. Ipamorelin has no Drugs@FDA application.
Ipamorelin vs CJC-1295 (No DAC): current prices and packages
| Compared property | Ipamorelin | CJC-1295 (No DAC) |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Compared package | 10mg | 5mg |
| Lowest current price | No current in-stock price | No current in-stock price |
| Price per labelled mg | — | — |
| Package sizes | 2mg, 5mg, 10mg | 2mg, 5mg, 10mg |
| Vendors with current prices | 0 | 0 |
| Form at this package | No listing | No listing |
| Stock | Out of stock | Out of stock |
Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.
Identity, regulatory status and registered research
| Compared property | Ipamorelin | CJC-1295 (No DAC) |
|---|---|---|
| Molecular formula | C38H49N9O5 | Not resolved |
| Molecular weight | 711.9 g/mol | — |
| Sequence | H-Aib-His-D-2Nal-D-Phe-Lys-NH2 (5 residues) | — |
| CAS Registry Number | 170851-70-4 | — |
| Registered clinical trials | 2 · Phase 2: 2 | None recorded |
| Human intervention studies | 2 | None recorded |
| US regulatory status | No Drugs@FDA application (checked October 7, 2026) · Drugs@FDA search | No reviewed Drugs@FDA record |
Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.
Key human studies
Ipamorelin
- Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. International journal of colorectal disease, 2014
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical research, 1999
CJC-1295 (No DAC)
No human intervention study is recorded in the research library for this identity.
Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.
Where to buy each compound
Ipamorelin
Ipamorelin is a five-amino-acid growth hormone secretagogue. Its original characterization used cell and animal experiments; a later human trial investigated a specific postoperative setting.
No vendor has a current in-stock price for this package.
Ipamorelin prices →Price history →CJC-1295 (No DAC)
FDA’s chemical review distinguishes a 29-amino-acid CJC-1295 free base from DAC-bearing forms. This catalogue entry separates the no-DAC label from the long-acting DAC compound.
No vendor has a current in-stock price for this package.
CJC-1295 (No DAC) prices →Price history →Related comparisons
Questions
Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price, except that the labelled featured partner, LA Peptides, is pinned first; “Cheapest” always marks the lowest price. PeptideTech earns a commission when you buy through a link.
Full method →